A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
מצבים רפואיים
Solid Tumor
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
National GCP Center for Anticancer Drugs,The Independent Ethics Committee, Beijing, Beijing Municipality, China
The Cancer Hospital of the Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Hunan Cancer Hospital, Hunan, Changsha, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China
Yuebei People's Hospital, Shaoguan, Guangdong, China
The First Affiliated Hospital of Guilin Medical Universty, Guilin, Guangxi, China
Liuzhou Workers' Hospital, Liuzhou, Guangxi, China
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
SIR RUN RUN SHAW Hospital Zhejiang University School Of Medicine, Hangzhou, Zhejiang, China
מובילי המחקר
Jing wang
Principal Investigator
Hunan Cancer Hospital
LingYIng Wu
Principal Investigator
The Cancer Hospital of the Chinese Academy of Medical Sciences